For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. This role will serve as a technical platform owner for Databricks, with particular focus on Databricks AI/BI and Genie, while also ensuring the reliable operation, governance, and lifecycle management of our existing enterprise BI platforms, including Spotfire, Tableau, Qlik, and Power BI.